About ALM Ortho
ALM Ortho designs and makes custom titanium implants for complex orthopedic surgery, such as limb reconstruction, tumor removal, trauma and revision surgery. Each implant is designed from the patient's CT scan and printed on the company's own electron beam melting machine.
Founded in 2020, the company is based in Scarborough, Maine. Its co-founders are Brian McLaughlin, the chief technology officer, and Paul DeJuliis, the chief financial officer. Since September 2026, Shoulder Innovations (NYSE: SI) has held the exclusive U.S. rights to offer ALM Ortho's shoulder and arm implants.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | Jul 30, 2026 | $749,994of $5.0M target | 3 | $249K | EquityRule 506(c) | Form D ↗ |
| Jun 21, 2024 | Jul 8, 2024 | $135,004of $3.0M target | 4 | $33,751 | Equity, OptionsRule 506(c) | Form D ↗ |
| Total, two offerings | $884,998 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by ALM Ortho
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Oct 25, 2024 | Series A | $1M | Central Texas Angel Network and Keiretsu Forum (co-leads) | Orthopedic Design & Technology ↗ Silicon Hills News ↗ |
| Mar 5, 2021 | Seed | Undisclosed | Paul DeJuliis | Metal AM ↗ |
Why Investors Backed ALM Ortho
Investors backed ALM Ortho for custom titanium implants aimed at surgeries where standard parts fall short, such as limb reconstruction and failed joint replacements. The company designs each device from a patient's scans and prints it at its own plant in Maine. In September 2026 Shoulder Innovations, a listed implant maker, signed an exclusive deal to offer ALM Ortho's implants for complex shoulder cases in the United States.
The problem it targets
Some orthopedic cases have no good standard implant: limb lengthening, implants that anchor a prosthetic limb to the bone, revisions of failed joint replacements and severe trauma. ALM Ortho works with surgeons on exactly these cases. Shoulder Innovations, its new partner, believes no adequate solution exists today for severe shoulder deformity and other very complex revisions.
What the product does
ALM Ortho builds each implant from the patient's CT scan. It prints the device in medical-grade titanium on its own electron beam melting machine in Scarborough, Maine, and delivers it to the surgical team. The company sells this as "Implant as a Service."
Progress so far
In September 2026 Shoulder Innovations (NYSE: SI) took the exclusive U.S. rights to ALM Ortho's implants for the shoulder and arm. Its sales team will find suitable cases and connect surgeons with ALM Ortho, which designs, makes and ships the devices. In Florida, the distributor OMI sells ALM Ortho's patient-specific implants for complex and revision cases.
Who backs it
The Central Texas Angel Network and Keiretsu Forum, two angel investor groups, led a $1 million Series A in October 2024. "ALM Ortho's technology promises to be life-changing for a large segment of amputees," said Lance Adams of the Central Texas Angel Network's deal team. Christian Haller, a regional vice president at Keiretsu Forum, sits on ALM Ortho's board.
We wrote this summary from public statements by ALM Ortho and its investors. It is not investment advice.
ALM Ortho in the News
Leadership Team
Executive officers and directors listed on ALM Ortho's Form D filed Jul 30, 2026.
Earlier filings also listed Jeffrey Laniewski (director, last listed Jul 2024).